Name: OTLC Insider Trading Activity
Creator: Tracefour
License: https://www.usa.gov/government-works
Keywords: OTLC, insider trading, SEC Form 4, insider transactions

Question 1

How many SEC Form 4 insider filings does OTLC have?

Accepted Answer

Oncotelic Therapeutics, Inc. (OTLC) has 2 SEC Form 4 filings (5 transaction rows) in the rolling 365-day window, disclosed by 1 distinct insider. Most recent filing: Jun 25, 2026.

Question 2

When was the most recent SEC Form 4 filing for OTLC?

Accepted Answer

The most recent Form 4 filing for OTLC on Tracefour is dated Jun 25, 2026.

Question 3

Who is the most active insider at OTLC?

Accepted Answer

The most active SEC Form 4 filer at OTLC in the rolling window is CHAIRMAN AND CEO Trieu Vuong, with 5 filings.

Question 4

What is the net insider flow at OTLC over the last 6 months?

Accepted Answer

Over the trailing 180 days, insiders at OTLC have net bought $26K based on SEC Form 4 disclosures.

Question 5

What is the total insider buy and sell value at OTLC in the current window?

Accepted Answer

Inside the rolling window, insiders at OTLC bought $26K and sold $0 based on SEC Form 4 filings.

						Source
Trieu Vuong	CHAIRMAN AND CEO	Purchase	115,000	$5K	Jun 25	SEC ↗
Trieu Vuong	CHAIRMAN AND CEO	Purchase	75,000	$3K	Jun 25	SEC ↗
Trieu Vuong	CHAIRMAN AND CEO	Purchase	65,000	$3K	Jun 25	SEC ↗
Trieu VuongFirst filing	CHAIRMAN AND CEO	Purchase	239,759	$11K	Jun 17	SEC ↗
Trieu VuongFirst filing	CHAIRMAN AND CEO	Purchase	96,000	$4K	Jun 17	SEC ↗

OTLC

Related companies